Immunotherapy, Adoptive
Showing 1 - 25 of 3,701
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in New York (haplo-identical cells (donor), umbilical cord blood unit
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- haplo-identical cells (donor)
- umbilical cord blood unit (CBU)
-
New York, New YorkWeill Cornell Medical College
Dec 14, 2022
Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and Stroke (NINDS)
Completed
- Progressive Multifocal Leukoencephalopathy
- PyVST
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Sarcoma Trial in Turin (Autologous CIK)
Recruiting
- Sarcoma
- Autologous CIK
-
Turin, ItalyAOU Città della Salute e della Scienza di Torino - Presidio Infa
Aug 11, 2022
Cytomegalovirus Infections, Hematopoietic Stem Cell Transplant, Opportunistic Infections Trial in Cleveland (CMV specific
Recruiting
- Cytomegalovirus Infections
- +2 more
- CMV specific adoptive t-cells
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 26, 2022
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)
Recruiting
- Pediatric Sarcoma, Refractory
- Pediatric Sarcoma, Relapsed
- GEM/DOX + TGFBi expanded NK cells
-
Tampa, Florida
- +1 more
Jan 3, 2023
Late Complication From Kidney Transplant Trial in San Francisco (Treg infusion)
Completed
- Late Complication From Kidney Transplant
- Treg infusion
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 11, 2022
Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)
Terminated
- Merkel Cell Polyomavirus Infection
- Stage IV Merkel Cell Carcinoma AJCC v7
- Avelumab
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 25, 2022
Acute Myeloid Leukemia Trial in Pittsburgh (Neukoplast™ (NK-92))
Completed
- Acute Myeloid Leukemia
- Neukoplast™ (NK-92)
-
Pittsburgh, PennsylvaniaUPMC Cancer Center - Hillman Cancer Center
Mar 28, 2022
Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes
Recruiting
- Toxicity, Drug
- +2 more
- Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
-
Leiden, NetherlandsLeiden University Medical Center
Aug 16, 2022
Advanced Cancer, Metastatic Cancer Trial in Shanghai (biological, device, drug)
Recruiting
- Advanced Cancer
- Metastatic Cancer
- Autologous Adoptive immune cells
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Pudong Medical Center
Jun 24, 2022
Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)
Active, not recruiting
- Ewing Sarcoma
- +4 more
- Allogeneic HCT
- Donor NK Cell Infusion
-
Milwaukee, Wisconsin
- +1 more
Apr 5, 2022
Leukemia Trial in Seattle (Patient-derived CD22-specific CAR T-cells also expressing an EGFRt)
Active, not recruiting
- Leukemia
- Patient-derived CD22-specific CAR T-cells also expressing an EGFRt
-
Seattle, WashingtonSeattle Children's Hospital
Feb 15, 2022
Viral Infection Trial in Washington, Houston (CMV/AdV /EBV/BKV specific T cells)
Recruiting
- Viral Infection
- CMV/AdV /EBV/BKV specific T cells
-
Washington, District of Columbia
- +1 more
Aug 6, 2021
Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)
Completed
- Haematological Malignancies
- CD25/71 allodepleted donor T-cells
-
London, United Kingdom
- +1 more
Jul 18, 2022
CD 19+ Acute Leukemia Trial in Seattle (T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC))
Active, not recruiting
- CD 19+ Acute Leukemia
- T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)
-
Seattle, WashingtonSeattle Children's Hospital
Mar 22, 2022
CMV Infection After Allogenic HSCT Trial in Beijing (CMV-TCR-T cells)
Recruiting
- CMV Infection After Allogenic HSCT
- CMV-TCR-T cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 5, 2021
COVID Trial in Bogotá, Bogota (Allogeneic NK transfer)
Withdrawn
- COVID
- Allogeneic NK transfer
-
Bogotá, Bogotá Distrito Capital, Colombia
- +1 more
Apr 29, 2021
Metastatic Breast Cancer Trial in Duarte (huMNC2-CAR44 CAR T cells, huMNC2-CAR44 CAR T cells @ RP2D)
Recruiting
- Metastatic Breast Cancer
- huMNC2-CAR44 CAR T cells
- huMNC2-CAR44 CAR T cells @ RP2D
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 22, 2021
Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)
Active, not recruiting
- Medulloblastoma
- Neuroectodermal Tumor
- TTRNA-xALT
- TTRNA-DCs
-
Los Angeles, California
- +2 more
Jan 7, 2022
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+
Active, not recruiting
- Metastatic Malignant Neoplasm in the Liver
- Metastatic Uveal Melanoma
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Leukemia, Lymphoma Trial in Canada, United States (Patient-derived CD19- and CD22 specific CAR)
Recruiting
- Leukemia
- Lymphoma
- Patient-derived CD19- and CD22 specific CAR
-
Los Angeles, California
- +4 more
Apr 2, 2022
Hepatocellular Carcinoma Trial in Beijing (adoptive immunotherapy, MWA)
Completed
- Hepatocellular Carcinoma
- adoptive immunotherapy
- MWA
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Mar 2, 2021
Epstein-Barr Virus Infections, Cytomegalovirus Infections, Adenovirus Trial in New York (Rapidly generated virus specific T
Not yet recruiting
- Epstein-Barr Virus Infections
- +3 more
- Rapidly generated virus specific T (R-MVST) cells
-
New York, New YorkColumbia University Irving Medical Center
Feb 18, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 3, 2022